Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MOSS, Inc. is a specialized biotechnology company that manufactures high-quality, liquid-stable immunoassay reagents for the diagnostics, pharmaceutical, and life science industries. For over 30 years, the company has focused on the development of stable substrates and conjugates, including TMB (tetramethylbenzidine) and various enzyme-linked components. Their core technology centers on liquid stabilization, which ensures long-term shelf life and lot-to-lot consistency for critical assay components. MOSS provides bulk manufacturing services and custom conjugation to support global partners in assay development and production. The company operates out of an ISO 9001:2015 certified facility in Maryland, USA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on M.O.S.S..